Jessica Edwards

Jessica’s recent experience includes advising:

• IDEX Corporation in its US$1 billion acquisition of Mott Corporation.
• Novo Holdings on its £50 million investment in Oxford Nanopore Technologies.
• One Equity Partners and Buckthorn Partners in their Acquisition of Acteon Group.
• Great Hill Partners on its pending strategic majority investment in a newly formed organisation comprising Vivup, a leading provider of health and well-being benefits, and Perkbox, an award-winning global benefits and reward platform, which will combine to offer a market-leading solution for the UK’s public and private employee benefits sectors.
• Coupang, Inc. in the completion of its acquisition of the business and assets of Farfetch Holdings plc via a pre-pack administration.
• Savillex Corporation, a portfolio company of private equity fund Thompson Street Capital Partners, in its strategic acquisition of ONFAB from Foresight Capital Partners.
• Gamma Biosciences, a life sciences platform created by global investment firm KKR, in the divestiture of its operating company Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, to Donaldson Company, Inc (NYSE: DCI).
• IDEX Corporation in its definitive agreement to acquire micro-precision technology manufacturing company Muon B.V. and its subsidiaries from Rivean Capital for a cash consideration of €700 million.
• EQT Private Equity and PRO Unlimited in PRO Unlimited’s acquisition of outsourced workforce management provider Geometric Results, Inc. 
• EQT Private Equity and Verdane in the sale of Forsta, an industry-leading global provider of customer experience and market research technology, to Press Ganey, a leader in patient, member, employee, and consumer experience across the healthcare ecosystem.
• Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, in its acquisition of the treaty reinsurance brokerage operations of Willis Towers Watson for US$3.25 billion.
• KKR on its majority acquisition of Biosynth Carbosynth, a Swiss life sciences reagents and custom synthesis and manufacturing services company.
• Crayhill Capital Management on its US$200 million financing of Heroes, a UK-based technology-driven ecommerce company.
• Invel Real Estate on the restructuring and refinancing of its acquisition of a significant interest in a publicly listed Greek property owning REIT.
• TowerBrook Capital Partners in its sale of and re-investment in Independent Clinical Services Group to Onex Corporation.
• ACPS Automotive, a technology and market leader in towbars/hitches for cars, SUVs, and vans, on the completion of its financial restructuring.
• TowerBrook Capital Partners on the acquisition of CarTrawler.
• TowerBrook Capital Partners on the acquisition of the Azzurri Group.
• H.I.G. Europe and its portfolio Vernacare on its acquisition of the industry leading Infection Prevention business providing an extensive range of sharps and clinical waste disposal solutions (including brands Sharpsafe®, Clinisafe®, and eXchange™) from the Frontier Medical Group (backed by Kester Capital).
• KKR on its investment and follow-on investment in music platform Artlist.
• All Seas Capital on its structured capital investment in Hakim, the UK’s leading independent chain of opticians.
• KKR on the creation of a pan-European logistics development platform.